Hawkins (HWKN) to Post Earnings on Wednesday

Hawkins (NASDAQ:HWKN) will likely be posting its Q1 2027 results after the market closes on Wednesday, July 29th. Analysts expect Hawkins to announce earnings of $1.41 per share and revenue of $313.4220 million for the quarter. Interested persons may review the information on the company’s upcoming Q1 2027 earning overview page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 4:10 PM ET.

Hawkins (NASDAQ:HWKN) last announced its quarterly earnings results on Wednesday, May 13th. The specialty chemicals company reported $0.74 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). The company had revenue of $265.91 million during the quarter, compared to analyst estimates of $255.28 million. Hawkins had a net margin of 7.53% and a return on equity of 16.08%. On average, analysts expect Hawkins to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Hawkins Price Performance

Shares of NASDAQ HWKN opened at $140.39 on Tuesday. The stock has a market capitalization of $2.94 billion, a price-to-earnings ratio of 35.91, a PEG ratio of 2.51 and a beta of 0.78. Hawkins has a 12 month low of $117.98 and a 12 month high of $186.15. The firm’s 50 day simple moving average is $150.03 and its 200-day simple moving average is $150.43. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.21 and a quick ratio of 1.46.

Hawkins Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were paid a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.5%. The ex-dividend date was Friday, May 29th. Hawkins’s payout ratio is currently 19.44%.

Analyst Ratings Changes

HWKN has been the topic of a number of recent analyst reports. Barclays set a $170.00 price target on shares of Hawkins and gave the stock an “equal weight” rating in a report on Tuesday, June 30th. Weiss Ratings cut shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, July 14th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Hawkins presently has a consensus rating of “Hold” and a consensus price target of $185.00.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. AQR Capital Management LLC lifted its position in shares of Hawkins by 9.0% during the 1st quarter. AQR Capital Management LLC now owns 12,331 shares of the specialty chemicals company’s stock valued at $1,306,000 after buying an additional 1,017 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Hawkins by 4.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,499 shares of the specialty chemicals company’s stock worth $1,218,000 after acquiring an additional 494 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Hawkins by 9.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 52,778 shares of the specialty chemicals company’s stock worth $5,590,000 after acquiring an additional 4,400 shares in the last quarter. Jane Street Group LLC raised its position in Hawkins by 83.2% during the first quarter. Jane Street Group LLC now owns 38,416 shares of the specialty chemicals company’s stock worth $4,069,000 after acquiring an additional 17,447 shares during the period. Finally, Invesco Ltd. raised its position in Hawkins by 50.3% during the second quarter. Invesco Ltd. now owns 282,349 shares of the specialty chemicals company’s stock worth $40,122,000 after acquiring an additional 94,503 shares during the period. 69.71% of the stock is owned by institutional investors and hedge funds.

Hawkins Company Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.